期刊文献+

药师指导下应用保肝药对预防抗肿瘤药物肝损伤及用药合理性的影响 被引量:2

Effect of liver protective drugs under the guidance of pharmacists on the prevention of liver injury and rationality of anti-tumor drugs
下载PDF
导出
摘要 目的探讨药师指导下应用保肝药对预防抗肿瘤药物肝损伤及用药合理性的影响。方法选取2018年4月至2020年4月于本院接受抗肿瘤药物治疗的90例患者作为研究对象,采用奇偶数法分为参照组与研究组,每组45例。参照组未给予药师干预,研究组给予药师干预,比较两组用药不合理发生率、肝损伤发生率及满意度。结果研究组用药不合理发生率低于参照组,差异有统计学意义(P<0.05)。研究组肝损伤发生率低于参照组,差异有统计学意义(P<0.05)。研究组用药满意度高于参照组,差异有统计学意义(P<0.05)。结论采用保肝药预防抗肿瘤药物肝损伤收效甚微,需给予药师干预,提高用药合理性,可显著降低肝损伤发生率,提高用药满意度。
作者 王丹 WANG Dan
出处 《当代医学》 2022年第15期142-144,共3页 Contemporary Medicine
  • 相关文献

参考文献13

二级参考文献126

  • 1Tawfik Khoury,Ayman Abu Rmeileh,Liron Yosha,Ariel A.Benson,Saleh Daher,Meir Mizrahi.Drug Induced Liver Injury: Review with a Focus on Genetic Factors, Tissue Diagnosis, and Treatment Options[J].Journal of Clinical and Translational Hepatology,2015,3(2):99-108. 被引量:20
  • 2Christin Giordano,John Rivas,Xaralambos Zervos.An Update on Treatment of Drug-Induced Liver Injury[J].Journal of Clinical and Translational Hepatology,2014,2(2):74-79. 被引量:11
  • 3黄慧强,彭玉龙,蔡清清,林旭滨,李宇红,夏忠军,林桐榆,孙晓非,张力,徐光川,何友兼,姜文奇,管忠震.含吡柔比星联合化疗方案治疗392例非霍奇金淋巴瘤患者长期随访结果分析[J].中华血液学杂志,2005,26(10):577-580. 被引量:23
  • 4Bjornsson ES, Bergmann OM, Bjomsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland[J]. Gastroenterology, 2013, 144(7): 1419-1425.
  • 5Fontana RJ, Watkins PB, Bonkovsk-y HL, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct[J]. Drug Saf, 2009, 32(1): 55-68.
  • 6Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug- induced liver injury[J]. Am J Gastroenterol, 2014, 109(7): 950-966.
  • 7Li L, Jiang W, Wang J. Clinical analysis of 275 cases of acute drug- induced liver disease[J]. Front Med China, 2007, 1(1): 58-61.
  • 8Hoofnagle JH, Serrano J, Knoben JE, et al. LiverTox: a website on drug-induced liver injury[J]. Hepatology, 2013, 57(3): 873-874.
  • 9Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver[J]. Semin Liver Di, 2002, 22(2): 145-155.
  • 10Bjomsson ES. Epidemiology and risk factors for idiosyncratic drug- induced liver injury[J]. Semin Liver Dis, 2014, 34(2): 115-122.

共引文献423

同被引文献24

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部